Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 837

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 4
Chunk 837
---
, Inc. (OTCQB: INTI), a publicly traded pharmaceutical development
company focused on therapeutics for certain cancers and non-cancerous proliferation disorders, since December 2022. Ms. Yanez is also
Co-Founder and Chief Financial Officer of Santander Pharma Consulting, a privately held life sciences consulting firm that provides business
development and commercial strategy services to pharmaceutical, medical devices, and life science companies offering guidance throughout
all stages of commercial development, from inception to product launch, since February 2024. Ms. Yanez earned her B.A. in Business Management
from University South Florida and further distinguished her acumen with an MBA in Strategic Leadership from Rutgers School of Business, Cum
Laude.

Matthew
Pratt Whalen, CPA, is a Certified Public Accountant with over two decades of experience in public accounting and corporate
finance. Mr. Whalen currently serves as the Chief Financial Officer of Power Digital Marketing Inc., an industry leading digital marketing
agency, where he has driven significant revenue growth and led key financial transactions. Specifically, Mr. Whalen oversees the finance
team, manages tax and audit relationships, and handles treasury management. Prior to joining Power Digital, from 2010 to May 2021, Mr.
Whalen was the Chief Financial Officer of MRC Smart Technology Solutions, a subsidiary of Xerox Corporation where he played a pivotal
role in growing the company’s revenue and managed diverse teams across multiple departments. Mr. Whalen holds a B.A. in Accounting
from the University of San Diego and is a Certified Public Accountant in California. Mr. Whalen has also served on the Finance Committee
of United Way San Diego. We believe that Mr. Whalen is qualified to serve as one of our directors based on his extensive experience in
finance and as a Certified Public Accountant. Mr. Whalen has also served as a director of MIRA Pharmaceuticals, Inc. (Nasdaq:MIRA)

 Dr.
Matthew Paul Del Giudice joined our company as a director in March 2024. Dr. Del Giudice has practiced as a radiologist since
2014. He currently serves as a general overnight emergency radiologist at the Cleveland Clinic and as a real estate investor with Comfort
Living, LLC. Prior to joining the Cleveland Clinic, from March 2021 to May 2022, Dr. Del Giudice was a general radiologist with Radiology
and Imaging Specialists in Lakeland, Florida. From July 201